Geode Capital Management’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $86.4K | Buy |
21,546
+9,153
| +74% | +$39.4K | ﹤0.01% | 4096 |
|
|
2026
Q2 | $31.7K | Sell |
12,393
-11,856
| -49% | -$23.5K | ﹤0.01% | 4314 |
|
|
2026
Q1 | $43.4K | Buy |
24,249
+18,019
| +289% | +$63.4K | ﹤0.01% | 4347 |
|
|
2025
Q4 | $34.3K | Sell |
6,230
-335
| -5% | -$2.71K | ﹤0.01% | 4302 |
|
|
2025
Q3 | $58K | Buy |
6,565
+3,811
| +138% | +$37.1K | ﹤0.01% | 4258 |
|
|
2025
Q2 | $20.8K | Hold |
2,754
| – | – | ﹤0.01% | 4356 |
|
|
2025
Q1 | $43.7K | Buy |
2,754
+280
| +11% | +$5.78K | ﹤0.01% | 4224 |
|
|
2024
Q4 | $62.5K | Buy |
2,474
+655
| +36% | +$17K | ﹤0.01% | 4203 |
|
|
2024
Q3 | $45.4K | Buy |
1,819
+784
| +76% | +$20.4K | ﹤0.01% | 4283 |
|
|
2024
Q2 | $29.8K | Buy |
+1,035
| New | +$39.1K | ﹤0.01% | 4391 |
|
|
2023
Q3 | – | Sell |
-220
| Closed | -$28.6K | – | 4759 |
|
|
2023
Q2 | $28.6K | Hold |
220
| – | – | ﹤0.01% | 4607 |
|
|
2023
Q1 | $48.1K | Hold |
220
| – | – | ﹤0.01% | 4529 |
|
|
2022
Q4 | $29K | Hold |
220
| – | – | ﹤0.01% | 4709 |
|
|
2022
Q3 | $48K | Buy |
220
+3
| +1% | +$1.35K | ﹤0.01% | 4772 |
|
|
2022
Q2 | $182K | Buy |
217
+1
| +0.5% | +$906 | ﹤0.01% | 4323 |
|
|
2022
Q1 | $271K | Buy |
216
+9
| +4% | +$12.3K | ﹤0.01% | 4226 |
|
|
2021
Q4 | $349K | Buy |
207
+53
| +34% | +$104K | ﹤0.01% | 4224 |
|
|
2021
Q3 | $412K | Buy |
154
+13
| +9% | +$27.2K | ﹤0.01% | 4119 |
|
|
2021
Q2 | $225K | Buy |
141
+16
| +13% | +$24.3K | ﹤0.01% | 4302 |
|
|
2021
Q1 | $188K | Hold |
125
| – | – | ﹤0.01% | 4131 |
|
|
2020
Q4 | $132K | Hold |
125
| – | – | ﹤0.01% | 4006 |
|
|
2020
Q3 | $173K | Hold |
125
| – | – | ﹤0.01% | 3759 |
|
|
2020
Q2 | $108K | Hold |
125
| – | – | ﹤0.01% | 3828 |
|
|
2020
Q1 | $101K | Hold |
125
| – | – | ﹤0.01% | 3763 |
|
|
2019
Q4 | $187K | Hold |
125
| – | – | ﹤0.01% | 3817 |
|
|
2019
Q3 | $116K | Hold |
125
| – | – | ﹤0.01% | 3913 |
|
|
2019
Q2 | $131K | Hold |
125
| – | – | ﹤0.01% | 3892 |
|
|
2019
Q1 | $267K | Buy |
125
+103
| +468% | +$307K | ﹤0.01% | 3651 |
|
|
2018
Q4 | $69K | Buy |
+22
| New | +$35.2K | ﹤0.01% | 3932 |
|
Other funds holding AZR
Geode Capital Management's AZR Position: Q3 2026 in Review
Geode Capital Management increased its Azora Therapeutics, Inc. Common Stock (AZR) stake by 74% in Q3 2026, buying an estimated $39.4K and bringing the position to 21,546 shares worth $86.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4096.
Geode Capital Management first reported a position in AZR in Q4 2018 and has held it in 29 quarters since. The position peaked at $412K in Q3 2021. 7 funds tracked by Wall St. Rank hold AZR as of Q3 2026.
- Geode Capital Management held 21,546 shares of Azora Therapeutics, Inc. Common Stock worth $86.4K as of Q3 2026.
- Geode Capital Management bought 9,153 Azora Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $39.4K.
- Azora Therapeutics, Inc. Common Stock made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4096 holding.
- Geode Capital Management first reported a position in Azora Therapeutics, Inc. Common Stock in Q4 2018 and has held it in 29 quarters since.
- Geode Capital Management's Azora Therapeutics, Inc. Common Stock position peaked at $412K in Q3 2021.
- 7 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.